Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cesium Radioisotopes | 1 | 2015 | 8 | 0.470 |
Why?
|
| X-Rays | 1 | 2015 | 31 | 0.470 |
Why?
|
| Transplantation Conditioning | 1 | 2015 | 304 | 0.410 |
Why?
|
| Bone Marrow Transplantation | 1 | 2015 | 612 | 0.370 |
Why?
|
| Animal Care Committees | 1 | 2011 | 1 | 0.350 |
Why?
|
| Macaca mulatta | 6 | 2011 | 501 | 0.340 |
Why?
|
| Dental Records | 1 | 2008 | 1 | 0.280 |
Why?
|
| Monkey Diseases | 1 | 2008 | 18 | 0.280 |
Why?
|
| Oral Hygiene | 1 | 2008 | 11 | 0.280 |
Why?
|
| Animal Identification Systems | 1 | 2025 | 3 | 0.240 |
Why?
|
| Artifacts | 1 | 2025 | 114 | 0.220 |
Why?
|
| Prostheses and Implants | 1 | 2025 | 152 | 0.210 |
Why?
|
| Device Removal | 1 | 2025 | 227 | 0.200 |
Why?
|
| Manganese | 1 | 2022 | 58 | 0.190 |
Why?
|
| Wakefulness | 1 | 2022 | 104 | 0.180 |
Why?
|
| Sp1 Transcription Factor | 1 | 2016 | 42 | 0.130 |
Why?
|
| Cellular Reprogramming Techniques | 1 | 2016 | 17 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2025 | 3831 | 0.120 |
Why?
|
| Cell Transdifferentiation | 1 | 2016 | 61 | 0.120 |
Why?
|
| Brain | 2 | 2025 | 3176 | 0.120 |
Why?
|
| Lethal Dose 50 | 1 | 2015 | 18 | 0.120 |
Why?
|
| Animals | 11 | 2025 | 34798 | 0.110 |
Why?
|
| Fibroblasts | 1 | 2016 | 861 | 0.100 |
Why?
|
| Thalidomide | 1 | 2011 | 40 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 2 | 2025 | 4754 | 0.090 |
Why?
|
| Myocytes, Cardiac | 1 | 2016 | 660 | 0.090 |
Why?
|
| Animals, Laboratory | 1 | 2011 | 12 | 0.090 |
Why?
|
| Antineoplastic Agents | 3 | 2011 | 1826 | 0.090 |
Why?
|
| Advisory Committees | 1 | 2011 | 151 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2016 | 917 | 0.080 |
Why?
|
| Carboxylic Acids | 1 | 2008 | 26 | 0.070 |
Why?
|
| Oligopeptides | 1 | 2008 | 116 | 0.070 |
Why?
|
| Benzimidazoles | 1 | 2009 | 132 | 0.070 |
Why?
|
| Stomatognathic Diseases | 1 | 2008 | 1 | 0.070 |
Why?
|
| Veterinary Medicine | 1 | 2008 | 8 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2011 | 393 | 0.070 |
Why?
|
| Anesthesia, Dental | 1 | 2008 | 8 | 0.070 |
Why?
|
| Mice | 3 | 2025 | 18466 | 0.070 |
Why?
|
| Pyrimidines | 1 | 2010 | 418 | 0.070 |
Why?
|
| Abscess | 1 | 2008 | 141 | 0.060 |
Why?
|
| Valproic Acid | 1 | 2007 | 163 | 0.060 |
Why?
|
| Postoperative Care | 1 | 2008 | 312 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 605 | 0.060 |
Why?
|
| Area Under Curve | 3 | 2010 | 321 | 0.050 |
Why?
|
| Rats | 2 | 2022 | 3609 | 0.050 |
Why?
|
| Spectrum Analysis | 1 | 2022 | 66 | 0.050 |
Why?
|
| Male | 6 | 2015 | 64967 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2025 | 2140 | 0.040 |
Why?
|
| Metabolic Clearance Rate | 2 | 2009 | 131 | 0.040 |
Why?
|
| Half-Life | 2 | 2010 | 161 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2025 | 3011 | 0.040 |
Why?
|
| Administration, Oral | 2 | 2010 | 698 | 0.030 |
Why?
|
| MEF2 Transcription Factors | 1 | 2016 | 36 | 0.030 |
Why?
|
| GATA4 Transcription Factor | 1 | 2016 | 38 | 0.030 |
Why?
|
| T-Box Domain Proteins | 1 | 2016 | 122 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2016 | 862 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2016 | 791 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 373 | 0.030 |
Why?
|
| Swine | 1 | 2016 | 1182 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2016 | 712 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2016 | 925 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2011 | 351 | 0.020 |
Why?
|
| Thiourea | 1 | 2010 | 10 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 1280 | 0.020 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2009 | 36 | 0.020 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2009 | 61 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2010 | 239 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2008 | 247 | 0.020 |
Why?
|
| Piperazines | 1 | 2010 | 257 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2009 | 322 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2010 | 286 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2009 | 354 | 0.020 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2007 | 86 | 0.020 |
Why?
|
| Models, Biological | 1 | 2010 | 1443 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2007 | 589 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 6448 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 4685 | 0.010 |
Why?
|
| Humans | 2 | 2016 | 132089 | 0.010 |
Why?
|